Feinberg J, Hoth D F
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore.
Hosp Pract (Off Ed). 1991 Mar 15;26(3):105-13. doi: 10.1080/21548331.1991.11707716.
Infections and malignancies account for most deaths in patients with AIDS--and will continue to do so as long as HIV-induced immunosuppression is progressive and irreversible. Options available for prevention and improved management of such diseases are changing as new agents emerge, new combinations of agents are developed, and new indications for available agents are identified.
感染和恶性肿瘤是艾滋病患者死亡的主要原因,只要由人类免疫缺陷病毒(HIV)引起的免疫抑制持续进展且不可逆,情况就会一直如此。随着新药物的出现、药物新组合的研发以及现有药物新适应症的确定,预防和改善此类疾病的可用方法也在不断变化。